Sarcolemmal and mitochondrial adenosine triphosphate-dependent potassium channels. Mechanism of desflurane-induced cardioprotection

Anesthesiology

Volumn 92, Issue 6, 2000, Pages 1731-1739

  Toller, Wolfgang G ^b   Gross, Eric R ^b   Kersten, Judy R ^a   Pagel, Paul S ^b   Gross, Garrett J ^b   Warltier, David C ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b NONE

Author keywords

Myocardial ischemia

Indexed keywords

1 [[5 [2 (5 CHLORO 2 ANISAMIDOETHYL] 2 METHOXYPHENYL]SULFONYL] 3 METHYLTHIOUREA; 5 HYDROXYDECANOIC ACID; ADENOSINE TRIPHOSPHATE; CALCIUM CHANNEL; CLAMIKALANT; DESFLURANE; GLIBENCLAMIDE; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA PRESSURE; ARTICLE; CHANNEL GATING; CONTROLLED STUDY; DOG; DRUG ANTAGONISM; HEART INFARCTION SIZE; HEART LEFT VENTRICLE PRESSURE; HEART MITOCHONDRION; HEART MUSCLE FIBER MEMBRANE; HEART PROTECTION; INHALATION ANESTHESIA; INTRACORONARY INFUSION; NONHUMAN; PRIORITY JOURNAL;

EID: 0034047770     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200006000-00033     Document Type: Article

References (43)

1. Auchampach JA, Grover GJ, Gross GJ: Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate. Cardiovasc Res 1992; 26: 1054-62
2. 1-receptors. Circulation 1992; 86:1310-6
3. ATP channels: Reduction of myocardial infarct size with an acute memory phase. ANESTHESIOLOGY 1997; 87:361-70
4. ATP channel antagonist, attenuates the cardioprotective effects of isoflurane in stunned myocardium. Anesth Analg 1996; 83: 27-33
5. Cason BA, Gamperl AK, Slocum RE, Hickey RF: Anesthetic-induced preconditioning: Previous administration of isoflurane decreases myocardial infarct size in rabbits. ANESTHESIOLOGY 1997; 87: 1182-90
6. Toller WG, Kersten JR, Pagel PS, Hettrick DA, Warltier DC: Sevoflurane reduces myocardial infarct size and decreases the time threshold for ischemic preconditioning in dogs. ANESTHESIOLOGY 1999; 91:1437-46
7. Gross GJ, Auchampach JA: Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 1992; 70:223-33
8. Toombs CF, Moore TL, Shebuski RJ: Limitation of infarct size in the rabbit by ischaemic preconditioning is reversible with glibenclamide. Cardiovasc Res 1993; 27:617-22
9. ATP) channels. ANESTHESIOLOGY 1996; 85:794-807
10. + channel in insulin secreting cells. Biochem Biophys Res Commun 1987; 146:21-5
11. Sturgess NC, Ashford ML, Cook DL, Hales CN: The sulphonylurea receptor may be an ATP-sensitive potassium channel. Lancet 1985; 2:474-5
12. ATP channel by glyburide and 5-hydroxydecanoate. J Biol Chem 1998; 273:13578-82
13. Stern MD, Silverman HS, Houser SR, Josephson RA, Capogrossi MC, Nichols CG, Lederer WJ, Lakatta EG: Anoxic contractile failure in rat heart myocytes is caused by failure of intracellular calcium release due to alteration of the action potential. Proc Natl Acad Sci U S A 1988; 85:6954-8
14. ATP) openers in models of myocardial ischemia and reperfusion. Can J Physiol Pharmacol 1997; 75:309-15
15. ATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs. Circulation 1994; 89:1769-75
16. ATP opener cromakalim is not correlated with ischemic myocardial action potential duration. J Cardiovasc Pharmacol 1995; 26:145-52
17. + channels: Possible mechanism of cardioprotection. Circ Res 1997; 81:1072-82
18. ATP channels and actin cytoskeleton. Am J Physiol 1999; 276:H1361-8
19. Billman GE, Englert HC, Scholkens BA: HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. Part II: Effects on susceptibility to ventricular fibrillation induced by myocardial ischemia in conscious dogs. J Pharmacol Exp Ther 1998; 286: 1465-73
20. Gogelein H, Hartung J, Englert HC, Scholkens BA: HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. Part I: Effects on cardiomyocytes, coronary flow and pancreatic beta-cells. J Pharmacol Exp Ther 1998; 286:1453-64
21. Liu Y, Sato T, O'Rourke B, Marban E: Mitochondrial ATP-dependent potassium channels: Novel effectors of cardioprotection? Circulation 1998; 97:2463-9
22. + channels by protein kinase C. Circ Res 1998; 83:110-4
23. McCullough JR, Normandin DE, Conder ML, Sleph PG, Dzwonczyk S, Grover GJ: Specific block of the anti-ischemic actions of cromakalim by sodium 5-hydroxydecanoate. Circ Res 1991; 69:949-58
24. American Physiologic Society: Guiding Principles in the Care and Use of Animals. Bethesda, 1991
25. Committee to Revise the Guide for the Care and Use of Laboratory Animals: Clark JD, Baldwin RL, Bayne KA, Brown MJ, Gebhart GF, Gonder JC, Gwathmey JK, Keeling ME, Kohn DF, Robb JW, Smith OA, Steggerda JD, Vandenbergh JG, White WJ, Williams-Blangero S, Vande-Berg JL: Guide for the Care and Use of Laboratory Animals. Edited by Grossblatt N. Washington, DC, National Academy Press, 1996
26. Warltier DC, Zyvoloski MG, Gross GJ, Hardman HF, Brooks HL: Determination of experimental myocardial infarct size. J Pharmacol Methods 1981; 6:199-210
27. Doorley BM, Waters SJ, Terrell RC, Robinson JL: MAC of 1-653 in beagle dogs and New Zealand white rabbits. ANESTHESIOLOGY 1988; 69:89-91
28. + channels in cardiac muscle. Nature 1983; 305:147-8
29. ATP channels: An endogenous protective mechanism during repetitive ischemia. Am J Physiol 1993; 264:H495-504
30. + channels protect the myocardium against ischemia/reperfusion damage. Circ Res 1991; 69:571-81
31. Nichols CG, Ripoll C, Lederer WJ: ATP-sensitive potassium channel modulation of the guinea pig ventricular action potential and contraction. Circ Res 1991; 68:280-7
32. + channels involves high-energy phosphate preservation. Am J Physiol 1993; 265:H1809-18
33. + channel subunits confer resistance to chemical hypoxia-reoxygenation injury. Circulation 1998; 98:1548-55
34. Gross GJ: Recombinant cardiac ATP-sensitive potassium channels and cardioprotection. Circulation 1998; 98:1479-80
35. Liu Y, Gao WD, O'Rourke B, Marban E: Cell-type specificity of preconditioning in an in vitro model. Basic Res Cardiol 1996; 91:450-7
36. ATP channel. Am J Physiol 1996; 271:H1769-77
37. + channel from rat liver and beef heart mitochondria. J Biol Chem 1992; 267:26062-9
38. ATP channel as a receptor for potassium channel openers. J Biol Chem 1996; 271:8796-9
39. + channel in mitochondria: Pharmacology and function. J Bioenerg Biomembr 1996; 28:147-52
40. Halestrap AP: The regulation of the matrix volume of mammalian mitochondria in vivo and in vitro and its role in the control of mitochondrial metabolism. Biochim Biophys Acta 1989; 973:355-82
41. + channels and myocardial preconditioning. Circ Res 1999; 84:973-9
42. +-ATPase modulates ischemic preconditioning. Circulation 1998; 98:2905-10
43. Lochner A, Harper IS, Salie R, Genade S, Coetzee AR: Halothane protects the isolated rat myocardium against excessive total intracellular calcium and structural damage during ischemia and reperfusion. Anesth Analg 1994; 79:226-33